Benzinga's Top Upgrade

Analysts at Oppenheimer upgraded OvaScience, Inc. OVAS from Market Perform to Outperform, according to Bloomberg. The price target for OvaScience is set to $55. OvaScience's shares closed at $40.51 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: UpgradesAnalyst RatingsTop Upgrade
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!